Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 10/20 | 0.45 |
| ▸ | HSP90B1 | P14625 | 6/20 | 0.45 |
| ▸ | PRKCB | P05771 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | TIPARP | Q7Z3E1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12840807 | 0.84 | HSP90AA1 (0.36) | HSP90AA1HSP90B1TIPARP | |
| SCHEMBL19498166 | 0.82 | HSP90AA1 (0.42) | HSP90AA1HSP90B1TIPARP | |
| SCHEMBL17623869 | 0.82 | HSP90AA1 (0.43) | HSP90AA1HSP90B1MEN1KMT2A | |
| SCHEMBL12840038 | 0.82 | HSP90AA1 (0.40) | HSP90AA1HSP90B1CYP1A2ALDH1A1MEN1 | |
| SCHEMBL12840031 | 0.78 | CHRM2 (0.37) | — | |
| SCHEMBL12840947 | 0.77 | HSP90AA1 (0.39) | HSP90AA1HSP90B1 | |
| SCHEMBL17624126 | 0.75 | TIPARP (0.50) | KDM1ATIPARPMEN1KMT2A | |
| SCHEMBL17623867 | 0.74 | HSP90AA1 (0.45) | HSP90AA1HSP90B1 | |
| SCHEMBL31598280 | 0.72 | HTR2C (0.46) | HSP90AA1HSP90B1 | |
| SCHEMBL8222559 | 0.71 | HSP90AA1 (0.50) | HSP90AA1HSP90B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170305922-A1 | CARM1 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2017-10-26 | — | — | US | disclosed |
| WO-2016044604-A1 | CARM1 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2016-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305922-A1 | CARM1 INHIBITORS AND USES THEREOF | CARM1, ADRM1, PRMT1 | HSP90AA1 1748/4885HSP90B1 783/4885PRKCB 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.